Humans

Kacey Ronaldson-Bouchard, Gordana Vunjak-Novakovic. Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development. Cell Stem Cell. 2018;22(3):310-324. doi:10.1016/j.stem.2018.02.011

Jarrod Bailey, Shiranee Pereira. Advances in neuroscience imply that harmful experiments in dogs are unethical. Journal of Medical Ethics. 2018;44(1):47-52. doi:10.1136/medethics-2016-103630

Janet Piñero, Laura I. Furlong, Ferran Sanz. In silico models in drug development: where we are. Current Opinion in Pharmacology. 2018;42:111-121. doi:10.1016/j.coph.2018.08.007

Sang Hun Lee, SoonGweon Hong, Jihwan Song, et al. Microphysiological Analysis Platform of Pancreatic Islet β-Cell Spheroids. Advanced Healthcare Materials. 2018;7(2). doi:10.1002/adhm.201701111

Dorothée Diogo, Chao Tian, Christopher S. Franklin, et al. Phenome-wide association studies across large population cohorts support drug target validation. Nature Communications. 2018;9(1):4285. doi:10.1038/s41467-018-06540-3

A. S. Khazali, A. M. Clark, A. Wells. A Pathway to Personalizing Therapy for Metastases Using Liver-on-a-Chip Platforms. Stem Cell Reviews and Reports. 2017;13(3):364-380. doi:10.1007/s12015-017-9735-3

Eduard Batlle, Hans Clevers. Cancer stem cells revisited. Nature Medicine. 2017;23(10):1124-1134. doi:10.1038/nm.4409

William G. Kaelin. Common pitfalls in preclinical cancer target validation. Nature Reviews. Cancer. 2017;17(7):425-440. doi:10.1038/nrc.2017.32

Shuo Xiao, Jonathan R. Coppeta, Hunter B. Rogers, et al. A microfluidic culture model of the human reproductive tract and 28-day menstrual cycle. Nature Communications. 2017;8:14584. doi:10.1038/ncomms14584

Melody Mills, Mary K. Estes. Physiologically relevant human tissue models for infectious diseases. Drug Discovery Today. 2016;21(9):1540-1552. doi:10.1016/j.drudis.2016.06.020